Related Experiment Video
Updated: May 13, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
A Novel Biallelic REL Frameshift Variant p.(Tyr9Ilefs*2) Causing Immunodeficiency-92 With Profound c-Rel Deficiency.
Mohsine-Ali El-Hamri1,2,3, Zineb Sabky1,2, Nada Benyahya1,2
1Department of Medical Genetics, National Institute of Hygiene, Rabat, Morocco.
A third case of immunodeficiency 92 (IMD92) caused by REL gene variants is reported in a child with novel symptoms. This finding expands the known spectrum of this rare disorder and highlights the importance of genetic sequencing for diagnosis.
Area of Science:
- Immunology
- Genetics
- Rare Diseases
Background:
- Inborn errors of immunity (IEI) are monogenic disorders affecting immune function.
- Immunodeficiency 92 (IMD92) is an extremely rare autosomal recessive disorder caused by pathogenic variants in the REL gene, affecting the NF-κB pathway.
- Only two patients with confirmed pathogenic REL variants have been previously reported.
Purpose of the Study:
- To describe a third case of IMD92.
- To expand the mutational spectrum of the REL gene.
- To emphasize the role of genetic sequencing in diagnosing IEI.
Main Methods:
- Clinical exome sequencing followed by Sanger sequencing.
- Western blot analysis of peripheral blood mononuclear cells.
Main Results:
- A novel homozygous frameshift variant (REL:c.24del p.(Tyr9Ilefs*2)) was identified in a 5-year-old child with combined immunodeficiency.
- The patient presented with chronic diarrhea, recurrent opportunistic infections, craniosynostosis, language delay, and epilepsy.
- The identified variant led to a severe reduction in c-Rel protein expression, confirming its functional impact.
Conclusions:
- This case expands the known REL mutational spectrum for IMD92.
- The findings underscore the critical role of c-Rel in human immune homeostasis.
- Next-generation sequencing, particularly clinical exome sequencing, is crucial for diagnosing and classifying IEI, enabling personalized patient management.
More Related Videos
14:14Simultaneous Quantification of T-Cell Receptor Excision Circles (TRECs) and K-Deleting Recombination Excision Circles (KRECs) by Real-time PCR
Published on: December 6, 2014
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Leaky Scanning
Point and Frameshift Mutations